SW
Chief Strategy Officer, Biology
Get the full picture
Sign in to uncover key details.
Quercus Molecular Design
Business Services · Connecticut, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 Farmington Ave, Farmington, Connecti...Phone Number
(415) 902-3256Revenue
$5.2 MillionIndustry
About Quercus Molecular Design
Quercus Molecular Design focuses on developing new therapeutic interventions for infectious diseases and cancer by leveraging fundamental discoveries from university laboratories. Originally targeting human herpesviruses, the company has expanded its antiviral efforts to include SARS-CoV-2 in response to the COVID-19 pandemic. Their innovative platform aims to create small molecule inhibitors that target multiple essential proteins, enhancing treatment potency and reducing drug resistance. The team comprises experts in molecular virology, drug resistance, cancer therapeutics, and medicinal chemistry, dedicated to advancing multi-targeting drug therapies.Explore more
SIC Code 87,873NAICS Code 54,541Show moreQuercus Molecular Design Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Quercus Molecular Design
Compare insights from companies similar to Quercus Molecular Design, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Quercus Molecular Design Tech Stack
A closer look at the technologies used by Quercus Molecular Design
See more technologies
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Quercus Molecular Design
Sign Up For FreeTo access detailed company insights
Quercus Molecular Design focuses on developing new therapeutic interventions for infectious diseases and cancer by leveraging fundamental discoveries from university laboratories. Originally targeting human herpesviruses, the company has expanded its antiviral efforts to include SARS-CoV-2 in response to the COVID-19 pandemic. Their innovative plat... Read More
